Protocol summary
-
Study aim
-
Evaluation the efficacy of anterior cruroplasty vs posterior .cruroplasty in improvement of Gastroesophageal reflux disease (GERD)after One-Anastomosis Gastric Bypass (OAGB)
-
Design
-
Clinical trial, with parallel groups, single-blind, randomized, on 90 patients
-
Settings and conduct
-
This trial will be conducted on 90 patients in Rasool-e Akram hospital. Patients will be blind.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 40<BMI<50, 18<age<65, Primary bariatric surgery
OAGB Surgical Procedure, BP Limb of 150 cm, Anastomosis diameter 4 cm
Symptomatic clinical GERD before OAGB, GERD grade A, B, C in pre-op endoscopy, Any size of hiatal hernia. Exclusion criteria were: High risk of anesthesia after heart and lung counseling, Diagnosing the surgeon based on the high risk of surgery, Lack of mental health: Serious psychological problem including psychosis and severe, uncontrollable depression at the discretion of the specialist, and Barrett's esophagus in pre-op endoscopy.
-
Intervention groups
-
1- Intervention group: One anastomosis gastric bypass without cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastr-jejunostomy about 150cm distal to Treitz' ligament.
2- Intervention group: One anastomosis gastric bypass with anterior cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastrojejunostomy about 150cm distal to Treitz' ligament. Then an anterior cruroplasty is performed with Ethibond 2-0.
3- Intervention group: One anastomosis gastric bypass with posterior cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastrojejunostomy about 150cm distal to Treitz' ligament. Then a posterior cruroplasty is performed with Ethibond 2-0.
-
Main outcome variables
-
Status of Gastroesophageal Reflux
General information
-
Reason for update
-
Hello. Respectfully The applied changes are: sample size: 90 (in three groups of 30) - place of study: Rasool-e Akram Hospital
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20190128042520N4
Registration date:
2022-11-23, 1401/09/02
Registration timing:
prospective
Last update:
2024-01-06, 1402/10/16
Update count:
1
-
Registration date
-
2022-11-23, 1401/09/02
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2023-01-20, 1401/10/30
-
Expected recruitment end date
-
2024-01-20, 1402/10/30
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Evaluation the efficacy of anterior cruroplasty versus posterior cruroplasty in improvement of Gastroesophageal reflux disease (GERD)after One Anastomosis Gastric Bypass (OAGB)
-
Public title
-
Evaluation the efficacy of diaphragmatic hernia repair in improvement of Gastroesophageal reflux disease (GERD)after One Anastomosis Gastric Bypass (OAGB)
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
40<BMI<50
18<age<65
Primary surgery
OAGB Surgery
Biliopancreatic limb length of 150 cm
Anastomosis length of 4 cm
Symptomatic clinical reflux before surgery
Reflux grade A, B, C in endoscopy
Having hiatal hernia in any size
Exclusion criteria:
High risk of anesthesia after heart and lung counseling
Diagnosing the surgeon based on the high risk of surgery
Lack of mental health: Serious psychological problem including psychosis and severe uncontrollable depression at the discretion of the specialist
Barrett's esophagus in pre-op endoscopy
-
Age
-
From 18 years old to 65 years old
-
Gender
-
Both
-
Phase
-
N/A
-
Groups that have been masked
-
-
Sample size
-
Target sample size:
90
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
In this study, we will use Block Randomization method with six block sizes. Excel software and rand() function will be used to prepare random order inside each block. We will have 3 groups of 30 people. When the intervention of each participant is determined, then a unique four-digit code will be assigned to the person (concealment). This number is the randomization code of the participant and the person will be identified with this number until the end of the study. A chain of 90 random allocations for use in the first phase of the study will be kept by the main investigator.
-
Blinding (investigator's opinion)
-
Single blinded
-
Blinding description
-
The patients are not aware about the type of surgery, but all types will describe before performing surgery and the aim of study completely clarify for them. This issue that the efficacy of these three methods on postoperative reflux is unknown, completely describe for the patients and they include in study after obtaining the informed consent.
-
Placebo
-
Not used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2022-11-16, 1401/08/25
-
Ethics committee reference number
-
IR.IUMS.REC.1401.646
Health conditions studied
1
-
Description of health condition studied
-
Gastro-esophageal reflux disease
-
ICD-10 code
-
K21
-
ICD-10 code description
-
Gastro-esophageal reflux disease
Primary outcomes
1
-
Description
-
Gastroesophageal Reflux Disease
-
Timepoint
-
Before surgery and 7 months after surgery
-
Method of measurement
-
Upper GI Endoscopy (esophagogastroduodenoscopy)
Intervention groups
1
-
Description
-
Intervention group 1: One anastomosis gastric bypass without cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastr-jejunostomy about 150cm distal to Trietz' ligament.
-
Category
-
Treatment - Surgery
2
-
Description
-
Intervention group 2: One anastomosis gastric bypass with anterior cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastr-jejunostomy about 150cm distal to Trietz' ligament. Then an anterior cruroplasty is performed with Ethibond 2-0.
-
Category
-
Treatment - Surgery
3
-
Description
-
Intervention group 3: One anastomosis gastric bypass with posterior cruroplasty: The pouch is created as a narrow and long pouch over a 36Fr bougie distal to Crow's foot with a 40mm gastr-jejunostomy about 150cm distal to Trietz' ligament. Then an posterior cruroplasty is performed with Ethibond 2-0.
-
Category
-
Treatment - Surgery
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Iran University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available